| No | Applicant Date | Invention Title | Applicants | Condition |
|---|---|---|---|---|
| 33 | 2021 | A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising Quinoline Derivatives as Active Ingredients | PCT | Pending application |
| 32 | 2020 | A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising Quinoline Derivatives as Active Ingredients | KOREA | Pending application |
| 31 | 2021 | A Contrast Agent Composition for Detecting Lesional Margin of Astrocytosis-Related Disease Comprising Quinoline Derivatives as Active Ingredients | PCT | Pending application |
| 30 | 2020 | A Contrast Agent Composition for Detecting Lesional Margin of Astrocytosis-Related Disease Comprising Quinoline Derivatives as Active Ingredients | KOREA | Patent registration |
| 29 | 2021 | A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising C11-Acetate as an Active Ingredient | PCT | Pending application |
| 28 | 2020 | A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising C11-Acetate as an Active Ingredient | KOREA | Pending application |
| 27 | 2020 | Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) | KOREA | Patent registration |
| 26 | 2020 | Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) | KOREA | Pending application |
| 25 | 2020 | Neural Plasticity Control Device and Method Using Theta-Burst Ultrasound | KOREA | Pending application |
| 24 | 2021 | Modified CRY2 with high photosensitivity and use of the same | U.S.A | Pending application |